Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cella

Showing results (851-860 of 955) with videos related to

Pageof 96
Sort By:
Neurourology and Urodynamics|November 26, 2019
Longitudinal changes in symptom-based female and male LUTS clustersCindy L Amundsen, Margaret E Helmuth, Abigail R Smith, et al.
JAMA Network Open|March 27, 2024
Patient-Reported Adverse Events and Early Treatment Discontinuation Among Patients With Multiple MyelomaJohn Devin Peipert, Fengmin Zhao, Ju-Whei Lee, et al.
Journal of Cancer Survivorship : Research and Practice|June 25, 2026
Effects of the Fit2Thrive technology-supported physical activity promotion intervention components on sedentary behavior and light physical activity in breast cancer survivorsKristina Hasanaj, Jean M Reading, Shirlene D Wang, et al.
Journal of Patient-Reported Outcomes|October 11, 2022
Linguistic validation of the Spanish version of the Anal Cancer High-Grade squamous intraepithelial lesions outcomes Research Health-Related Symptom Index (A-HRSI): AMC-A04Thomas M Atkinson, Kathleen A Lynch, Jacqueline Vera, et al.
Cancer|October 22, 2025
Overall side-effect bother consistently associated with early treatment discontinuation due to adverse events in four clinical trials with various cancer types and treatmentsJohn Devin Peipert, Shaili Ganatra, Fengmin Zhao, et al.
The Journal of Urology|May 7, 2018
Mental Health, Sleep and Physical Function in Treatment Seeking Women with Urinary IncontinenceNazema Y Siddiqui, Jonathan B Wiseman, David Cella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2013
Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trialRobert J Motzer, Dmitry Nosov, Timothy Eisen, et al.
Contemporary Clinical Trials|February 22, 2023
Effectiveness and implementation of an electronic health record-integrated digital health intervention for managing depressive symptoms in ambulatory oncology: The My Well-Being Guide study rationale and protocolBetina Yanez, Katherine A Czech, Diana Buitrago, et al.
JCO Clinical Cancer Informatics|December 10, 2025
Patient Portal Engagement in Oncology: Results From the NU IMPACT Study in a Large Health Care SystemKyle M Nolla, Maja Kuharic, Nicola Lancki, et al.
JHLT Open|June 9, 2025
Responsiveness validity for measures of adjustment to life with a left ventricular assist device: Findings from the MCS A-QOL studyElizabeth A Hahn, Larry A Allen, David Cella, et al.
Pageof 96

Showing results (851-860 of 955) with videos related to

Sort By:
Pageof 96
Neurourology and Urodynamics|November 26, 2019
Longitudinal changes in symptom-based female and male LUTS clustersCindy L Amundsen, Margaret E Helmuth, Abigail R Smith, et al.
JAMA Network Open|March 27, 2024
Patient-Reported Adverse Events and Early Treatment Discontinuation Among Patients With Multiple MyelomaJohn Devin Peipert, Fengmin Zhao, Ju-Whei Lee, et al.
Journal of Cancer Survivorship : Research and Practice|June 25, 2026
Effects of the Fit2Thrive technology-supported physical activity promotion intervention components on sedentary behavior and light physical activity in breast cancer survivorsKristina Hasanaj, Jean M Reading, Shirlene D Wang, et al.
Journal of Patient-Reported Outcomes|October 11, 2022
Linguistic validation of the Spanish version of the Anal Cancer High-Grade squamous intraepithelial lesions outcomes Research Health-Related Symptom Index (A-HRSI): AMC-A04Thomas M Atkinson, Kathleen A Lynch, Jacqueline Vera, et al.
Cancer|October 22, 2025
Overall side-effect bother consistently associated with early treatment discontinuation due to adverse events in four clinical trials with various cancer types and treatmentsJohn Devin Peipert, Shaili Ganatra, Fengmin Zhao, et al.
The Journal of Urology|May 7, 2018
Mental Health, Sleep and Physical Function in Treatment Seeking Women with Urinary IncontinenceNazema Y Siddiqui, Jonathan B Wiseman, David Cella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2013
Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trialRobert J Motzer, Dmitry Nosov, Timothy Eisen, et al.
Contemporary Clinical Trials|February 22, 2023
Effectiveness and implementation of an electronic health record-integrated digital health intervention for managing depressive symptoms in ambulatory oncology: The My Well-Being Guide study rationale and protocolBetina Yanez, Katherine A Czech, Diana Buitrago, et al.
JCO Clinical Cancer Informatics|December 10, 2025
Patient Portal Engagement in Oncology: Results From the NU IMPACT Study in a Large Health Care SystemKyle M Nolla, Maja Kuharic, Nicola Lancki, et al.
JHLT Open|June 9, 2025
Responsiveness validity for measures of adjustment to life with a left ventricular assist device: Findings from the MCS A-QOL studyElizabeth A Hahn, Larry A Allen, David Cella, et al.
Pageof 96